Off-label letrozole for tubal pregnancy monotherapy is not an alternative to methotrexate: a prospective cohort study.

Iwona Magdalena Gawron Dorota Babczyk Joanna Figula

Published in: Ginekologia polska (2024)

Even though the results did not reach statistical significance, it is likely that a larger study sample would confirm the trend of letrozole being less effective. The results did not support the use of letrozole in the studied regimen as an alternative to MTX.

Keyphrases

polycystic ovary syndrome
early breast cancer
insulin resistance
open label
clinical trial
type diabetes
combination therapy
pregnant women
solid state